welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children
study id #: NCT02418338
condition: Duchenne Muscular Dystrophy
Compare systolic function of left ventricle (LV) and right ventricle (VD) by 2D strain evaluation in Duchenne muscular dystrophy children versus a control group.
intervention: speckle tracking (2D strain) echocardiography
mechanism of action: No pharmaceutical intervention
last updated: June 10, 2019
start date: January 2014
estimated completion: June 2017
phase of development: N/A
size / enrollment: 99
Among the new echocardiographic techniques, two dimensional Speckle Tracking Imaging or "2D Strain" allows a dynamic study of regionalized and global ventricular contraction. With software for the spatial and temporal processing of a standard 2D image, this technique measures the displacement of natural markers present on the myocardial wall.
Used in adult cardiology since 2000, it could be eligible to pediatric population because of many potential applications. In Duchenne muscular dystrophy, myocardial disease leads to death in the third decade. Early diagnosis and preventive therapy remain a challenge. No clinic, biologic or radiologic markers can predict myocardial disease before advanced and irreversible heart failure.
Recent animals and human studies suggest that 2D strain anomalies could predict left ventricular systolic dysfunction in Duchenne muscular dystrophy. If it is confirmed, 2D strain could be used as early marker of myocardial disease in routine patient follow-up and in future therapeutic studies.
Purpose : - To compare systolic function of left ventricle (LV) and right ventricle (RV) by 2D strain evaluation in Duchenne muscular dystrophy children versus a control group.
• To correlate 2D Strain variables to conventional LV and RV echo variables.
• To evaluate 2D strain feasibility in normal children and Duchenne muscular myopathy population
- global longitudinal LV 2D strain [ Time Frame: day 1 ]
• Duchenne's muscular dystrophy (group 1) followed in our institution's referral center of neuromuscular diseases, during regular annual echocardiography follow-up.
• Healthy children (group 2), addressed in pediatric cardiology
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular DystrophyStudy to characterize the single-state a...
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocortico...The purpose of the study is to assess th...
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)The purpose of this study is to determin...
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-infl...We report a first-in-patient study of va...
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular DystrophyThe study is to demonstrate non-inferior...
L-citrulline and Metformin in Becker’s Muscular DystrophyThe purpose of the study is to compare t...
Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular DystrophyBackground: - Duchenne muscular dystrop...
Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophyObjective: To explore the value of nucl...
Upper arm, pulmonary and cardiac magnetic resonance imaging for relative disease status in Duchenne muscular dystrop...Objective: To simultaneously assess the...
Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients wit...Capricor Therapeutics, Inc. (NASDAQ: CAP...
Catabasis Pharmaceuticals Presents Data Supporting MRI T2 as a Potential Marker of Clinical Outcome in Duchenne Musc...Catabasis Pharmaceuticals, Inc. (NASDAQ:...